Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported ...

The Food and Drug Administration has granted Fast Track designation to bempikibart for the treatment of alopecia areata.

Medically reviewed by Susan Bard, MD Alopecia areata is a common hair loss condition. It affects people of all ages, races, ...

While similarities exist between types of alopecia, distinct clinical characteristics help patients & physicians ...

This exciting colloquium was spearheaded by the Cicatricial Alopecia Research Foundation (C.A.R.F.). In this article, clinical aspects of six of the more common types of primary cicatricial ...

Studies show that both men and women can develop a disease that attacks the hair follicles and causes hair loss at any point ...

Alopecia areata causes patches of baldness about the size of a large coin - with both men and women equally affected. Kaz - donning her stylish cropped hairstyle - was back on-screen for the All ...

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial.

Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug to treat alopecia areata, an autoimmune condition causing patchy hair loss that affects more than 700,000 ...

Masumi Tsunoda, a 45-year-old woman in Maebashi, Gunma Prefecture, who is an alopecia areata patient, was asked to design a headscarf for Licca-chan. Tsunoda contracted the disease 10 years ago.